Sarcopenia

Among a cohort of adults aged at least 60 years, participants with diabetes or high HbA1c became frailer more quickly than those without either condition, particularly if cardiovascular disease also was present, according to findings published in Diabetes Care.

Long-term treatment with denosumab increased bone mineral density without any adverse effects in patients with autoimmune liver disease, specifically primary biliary cholangitis, according to the results of a pilot study.

Supervised progressive resistance training increased muscle strength and size in patients with compensated cirrhosis while also providing beneficial effects on general performance measures, according to a study published in Clinical Gastroenterology and Hepatology.